Dashboard
Analysis
Charting
Screener
Resources
Settings
NYSE-BABA
Mar '15
Sep '16
Mar '18
Sep '19
Mar '21
Sep '22
Mar '24
Sep '25
Trailing Valuation
Stock Price
1,272.4
960
744.7
522.5
633.3
701.7
Total Shares Outstanding
2,319
2,374.8
2,395
2,433.6
2,531.3
2,565.8
Market Cap
2,950,857.9
2,279,058.3
1,783,779.4
1,272,745.5
1,601,772.1
1,800,773.2
Total Enterprise Value (TEV)
2,983,426.9
2,215,696.3
1,751,570.4
1,058,496.5
1,362,971.1
1,575,813.2
Dividend Yield
—
0%
1.6%
1.4%
Buyback Yield
0.6%
4.1%
4.2%
2.1%
Debt Paydown Yield
-2%
-2.1%
-0.4%
0.2%
-0.6%
Shareholder Yield
-1.4%
2%
3.8%
2.3%
3.5%
P/S
6
4.4
3.7
2.6
3.5
3.9
P/Gross Profit
14.9
10.9
9.4
7.2
9.1
10.8
P/E
47.6
37.5
26.6
72.6
26.3
Earnings Yield
2.7%
P/OCF
95.9
11.6
27.4
16.9
15.2
P/FCF
16.2
50.3
8.2
19.4
21.3
FCF Yield
1%
6.2%
12.3%
5.1%
4.7%
P/B
2.8
2.3
1.9
1.3
1.5
1.8
EV/Sales
4.3
2.2
3
EV/Gross Profit
15
10.6
9.2
5.9
7.7
EV/EBITDA
73.9
19.8
24.6
12.9
17.9
EV/EBIT
31.8
28.4
31.3
EV/OCF
97
11.3
26.9
14.4
13.3
EV/FCF
15.8
49.4
6.8
16.5
18.7
Dividends
DPS
0
12.2
Payout Ratio
0.1%
42.6%
101.4%
Margins
Gross Profit Margin
40%
40.4%
39.5%
36.9%
38.6%
36.7%
Operating Margin
8.2%
13.5%
14.8%
7.7%
16.6%
11%
EBITDA Margin
21.7%
17%
21.3%
Net Profit Margin
12.7%
11.3%
14.1%
2.4%
13%
14.9%
Effective Tax Rate
18.6%
23.6%
20.5%
47.9%
16.5%
10.1%
Pre-Tax Profit Margin
15.6%
17.7%
4.6%
Free Cash Flow Margin
27.2%
7.4%
32.4%
18%
18.5%
OCF / Sales
38.1%
13.6%
36.5%
20.6%
26%
OCF / Net Income
48.8%
337.1%
96.3%
1,513.5%
158.4%
175.3%
FCF / OCF
100%
71.4%
54.5%
88.6%
87.2%
71.1%
FCF / Net Income
240.5%
52.5%
1,341.5%
138.1%
124.7%
FCF / EBITDA
76.2%
125.3%
49.8%
190.9%
108.4%
86.9%
Capital Efficiency
Return on Invested Capital
2.5%
1.7%
5.5%
3.9%
Return on Assets
1.8%
3%
3.2%
1.1%
3.6%
2.6%
Return on Equity
5.7%
5.4%
6.1%
5.3%
Return on Total Capital
9.8%
17.3%
6.5%
15.3%
Return on Capital Employed
2.9%
5.2%
3.7%
Return on Tangible Assets
4.5%
0.8%
4.8%
Asset Turnover
0.3
Fixed Asset Turnover
2.5
CapEx to OCF
0.5
0.1
CapEx to Revenue
CapEx to Depreciation
0.4
0.7
Financial Health
Total Debt
281,594
230,703
202,260
170,776
166,744
161,354
Net Debt
-46,721
-143,610
-136,262
-340,304
-373,765
-358,224
Current Ratio
1.4
Quick Ratio
0.9
0.8
1.2
Cash Ratio
Debt Ratio
Assets to Equity
1.6
1.7
Cash Flow to Debt Ratio
1
0.6
Long-term Debt to Assets
Intangibles to Total Assets
0.2
Net Current Asset Value
-204,766
-120,320
-199,785
-25,421
-18,552
-65,421
Goodwill / Assets
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
-1.2
-1.3
-1.9
-4.2
-4.9
-3.7
EBIT / Interest Expense
8.1
14
15.4
8.7
20.9
15.3
EBITDA / Interest Expense
22.5
19
29.6
(EBITDA - Capex) / Interest Expense
11.2
9
14.3
17.6
19.1
Per Share
Revenue per Share
206.9
215.5
197.2
191.4
178.5
174.5
Basic EPS
27.6
26.5
28.6
7.3
24.3
Diluted EPS
26.7
25.6
28
24.1
Book Value per Share
446.3
421.3
392.2
391.7
402.6
378.8
Tangible Book Value per Share
331.5
306
276
277.9
282.7
258.3
Cash per Share
137.1
156.2
139.2
202.9
210.2
198.9
Operating Cash Flow per Share
82.1
26.8
69.9
36.8
45.5
Free Cash Flow per Share
58.6
14.6
62
32.1
32.3
CapEx per Share
23.5
7.9
4.7
13.1
Weighted Avg. Shares Outstanding
2,320.3
2,317.1
2,380.6
2,493.8
2,551.8
2,591.1
Weighted Avg. Shares Outstanding Diluted
2,394.3
2,397.1
2,432.4
2,518.9
2,570.9
2,612.4
Common Size
R&D to Revenue
6.9%
6%
SG&A to Revenue
27.1%
19.4%
18.4%
18.7%
15.1%
Stock-based Comp to Revenue
